Catheter Precision announces two patents to be issued by USPTO

Catheter Precision (VTAK) received notification from the United States Patent and Trademark Office of the allowance for issuance of two new patents. One patent is entitled “Methods of Ventricular Arrhythmia Localization Using a 3D Model”. This patent is another milestone of adding to the VIVO technology intellectual property portfolio, and will be assigned to Kardionav, the joint venture between Catheter Precision and physicians to bring in new applications to cardiac ventricular therapies. The second patent is entitled, “Neurostimulation Devices and Methods”, which is oriented toward improvement of cardiac ventricular function, especially in patients with heart failure. This patent will be assigned to Cardionomix, a majority owned subsidiary of Catheter Precision. Cardionomix holds a number of patents, with the intent to pursue heart failure therapy, primarily through stimulation of certain nerve endings found in the pulmonary arteries.